Cassandra A. Stanton
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Cassandra A. Stanton has a total of 317 co-authors. Here are the top co-authors by number of shared publications:
- Eva Sharma
Westat, Rockville, MD, USA
59 shared publications - Heather L. Kimmel
National Institute on Drug Abuse, National Institutes of Health , Bethesda, MD
59 shared publications - Kathryn C. Edwards
Westat Inc , Rockville, MD
54 shared publications - Maciej Lukasz Goniewicz
Department of Health Behavior, Roswell Park Comprehensive Cancer Center, Buffalo, New York, USA
51 shared publications - Andrea C. Villanti
Rutgers Institute for Nicotine and Tobacco Studies, Rutgers Health , New Brunswick, NJ 08901
50 shared publications - Jennifer Pearson
University of Nevada, Reno, Reno, NV, USA
49 shared publications
Latest Publications
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Supplemental Table 2 from Validating Wave 1 (2014) Urinary Cotinine and TNE-2 Cut-points for Differentiating Wave 4 (2017) Cigarette Use from Non-use in the United States Using Data from the PATH Study
Supplemental Table 2 provides demographic and tobacco use characteristics of any tobacco users.
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplemental Table 2 from Validating Wave 1 (2014) Urinary Cotinine and TNE-2 Cut-points for Differentiating Wave 4 (2017) Cigarette Use from Non-use in the United States Using Data from the PATH Study
Supplemental Table 2 provides demographic and tobacco use characteristics of any tobacco users.
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Supplemental Table 5 from Validating Wave 1 (2014) Urinary Cotinine and TNE-2 Cut-points for Differentiating Wave 4 (2017) Cigarette Use from Non-use in the United States Using Data from the PATH Study
Supplemental Table 5 provides Wave 1 and Wave 4 cotinine cut-points for any tobacco use.
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplemental Table 5 from Validating Wave 1 (2014) Urinary Cotinine and TNE-2 Cut-points for Differentiating Wave 4 (2017) Cigarette Use from Non-use in the United States Using Data from the PATH Study
Supplemental Table 5 provides Wave 1 and Wave 4 cotinine cut-points for any tobacco use.
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Supplemental Figure 1 from Validating Wave 1 (2014) Urinary Cotinine and TNE-2 Cut-points for Differentiating Wave 4 (2017) Cigarette Use from Non-use in the United States Using Data from the PATH Study
Supplemental Figure 1 shows the analytic sample flow chart.
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplemental Figure 1 from Validating Wave 1 (2014) Urinary Cotinine and TNE-2 Cut-points for Differentiating Wave 4 (2017) Cigarette Use from Non-use in the United States Using Data from the PATH Study
Supplemental Figure 1 shows the analytic sample flow chart.
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Supplemental Table 1 from Validating Wave 1 (2014) Urinary Cotinine and TNE-2 Cut-points for Differentiating Wave 4 (2017) Cigarette Use from Non-use in the United States Using Data from the PATH Study
Supplemental Table 1 provides demographic and tobacco use characteristics of exclusive and polytobacco users.
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplemental Table 1 from Validating Wave 1 (2014) Urinary Cotinine and TNE-2 Cut-points for Differentiating Wave 4 (2017) Cigarette Use from Non-use in the United States Using Data from the PATH Study
Supplemental Table 1 provides demographic and tobacco use characteristics of exclusive and polytobacco users.
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Supplemental Table 6 from Validating Wave 1 (2014) Urinary Cotinine and TNE-2 Cut-points for Differentiating Wave 4 (2017) Cigarette Use from Non-use in the United States Using Data from the PATH Study
Supplemental Table 6 provides Wave 1 and Wave 4 TNE-2 cut-points for any tobacco use.
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplemental Table 6 from Validating Wave 1 (2014) Urinary Cotinine and TNE-2 Cut-points for Differentiating Wave 4 (2017) Cigarette Use from Non-use in the United States Using Data from the PATH Study
Supplemental Table 6 provides Wave 1 and Wave 4 TNE-2 cut-points for any tobacco use.
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Supplemental Table 3 from Validating Wave 1 (2014) Urinary Cotinine and TNE-2 Cut-points for Differentiating Wave 4 (2017) Cigarette Use from Non-use in the United States Using Data from the PATH Study
Supplemental Table 3 provides prevalence rates of any tobacco use using cotinine cut-points.
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplemental Table 3 from Validating Wave 1 (2014) Urinary Cotinine and TNE-2 Cut-points for Differentiating Wave 4 (2017) Cigarette Use from Non-use in the United States Using Data from the PATH Study
Supplemental Table 3 provides prevalence rates of any tobacco use using cotinine cut-points.
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Supplemental Table 4 from Validating Wave 1 (2014) Urinary Cotinine and TNE-2 Cut-points for Differentiating Wave 4 (2017) Cigarette Use from Non-use in the United States Using Data from the PATH Study
Supplemental Table 4 provides prevalence rates of any tobacco use using TNE-2 cut-points.
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplemental Table 4 from Validating Wave 1 (2014) Urinary Cotinine and TNE-2 Cut-points for Differentiating Wave 4 (2017) Cigarette Use from Non-use in the United States Using Data from the PATH Study
Supplemental Table 4 provides prevalence rates of any tobacco use using TNE-2 cut-points.
- Open Access
- 3 June 2026
- Published by Oxford University Press (OUP) in Nicotine & Tobacco Research
Pre-pregnancy depression, prenatal care, and e-cigarette/cigarette use during late pregnancy among adolescents
Introduction: Although robust evidence shows a link between depression and tobacco use among adolescents, little information exists concerning pregnant adolescents. As such, we examined: (1) the association between pre-pregnancy depression and e-cigarette/cigarette use during late pregnancy and (2) whether prenatal care visit frequency moderates this association. Methods: We analyzed data from 10 363 adolescents (ages 19 or younger) in the U.S. Pregnancy Risk Assessment Monitoring System (2016–2021), a national cross-sectional survey supplemented with birth certificates. Participants reported pre-pregnancy depression and e-cigarette and cigarette use in the last 3 months of pregnancy. Multivariable logistic regression models estimated (1) associations of depression with e-cigarette/cigarette use and (2) the interaction between depression and prenatal care visit frequency, adjusting for sociodemographic and pregnancy-related confounders. Results: Adolescents with pre-pregnancy depression were as likely to use e-cigarettes exclusively during late pregnancy as those without pre-pregnancy depression (3.21% vs. 1.66%; confounder-adjusted odds ratio [aOR], 1.33 [95% CI, 0.78-2.27]). However, those with pre-pregnancy depression were more likely to use cigarettes exclusively (12.72% vs. 4.81%; 1.94 [1.44-2.61]) or use both e-cigarettes and cigarettes (3.50% vs. 0.59%; 4.62 [2.18-9.81]) during late pregnancy. The association between pre-pregnancy depression and exclusive cigarette use was weaker (interaction P < .05) among adolescents with 9-11 prenatal care visits (1.38 [0.82-2.32]) and ≥ 12 prenatal care visits (1.77 [1.10-2.84]) compared to those with ≤8 prenatal care visits (3.86 [2.23-6.67]). Conclusions: Pre-pregnancy depression was associated with cigarette smoking and dual use of e-cigarettes and cigarettes, but not exclusive e-cigarette use, in pregnant adolescents. Frequent prenatal care seemed to partially buffer the elevated risk of cigarette use associated with pre-pregnancy depression in this observational research. Implications: This study is one of the first to examine how prenatal care can modify the relationship between depression and tobacco use among U.S. pregnant adolescents. Our results indicated that pre-pregnancy depression was associated with cigarette use or dual use of e-cigarettes and cigarettes, but not with exclusive use of e-cigarettes. Adequate prenatal care seemed to partially buffer the elevated risk of cigarette use associated with pre-pregnancy depression in this observational research. Upon replication, our research has potential implications for clinical practice and public health policy to improve maternal and child health, especially through addressing mental health and tobacco use in the prenatal care setting.
- 3 June 2026
- Published by Oxford University Press (OUP) in Nicotine & Tobacco Research
Open AccessPre-pregnancy depression, prenatal care, and e-cigarette/cigarette use during late pregnancy among adolescents
Introduction: Although robust evidence shows a link between depression and tobacco use among adolescents, little information exists concerning pregnant adolescents. As such, we examined: (1) the association between pre-pregnancy depression and e-cigarette/cigarette use during late pregnancy and (2) whether prenatal care visit frequency moderates this association. Methods: We analyzed data from 10 363 adolescents (ages 19 or younger) in the U.S. Pregnancy Risk Assessment Monitoring System (2016–2021), a national cross-sectional survey supplemented with birth certificates. Participants reported pre-pregnancy depression and e-cigarette and cigarette use in the last 3 months of pregnancy. Multivariable logistic regression models estimated (1) associations of depression with e-cigarette/cigarette use and (2) the interaction between depression and prenatal care visit frequency, adjusting for sociodemographic and pregnancy-related confounders. Results: Adolescents with pre-pregnancy depression were as likely to use e-cigarettes exclusively during late pregnancy as those without pre-pregnancy depression (3.21% vs. 1.66%; confounder-adjusted odds ratio [aOR], 1.33 [95% CI, 0.78-2.27]). However, those with pre-pregnancy depression were more likely to use cigarettes exclusively (12.72% vs. 4.81%; 1.94 [1.44-2.61]) or use both e-cigarettes and cigarettes (3.50% vs. 0.59%; 4.62 [2.18-9.81]) during late pregnancy. The association between pre-pregnancy depression and exclusive cigarette use was weaker (interaction P < .05) among adolescents with 9-11 prenatal care visits (1.38 [0.82-2.32]) and ≥ 12 prenatal care visits (1.77 [1.10-2.84]) compared to those with ≤8 prenatal care visits (3.86 [2.23-6.67]). Conclusions: Pre-pregnancy depression was associated with cigarette smoking and dual use of e-cigarettes and cigarettes, but not exclusive e-cigarette use, in pregnant adolescents. Frequent prenatal care seemed to partially buffer the elevated risk of cigarette use associated with pre-pregnancy depression in this observational research. Implications: This study is one of the first to examine how prenatal care can modify the relationship between depression and tobacco use among U.S. pregnant adolescents. Our results indicated that pre-pregnancy depression was associated with cigarette use or dual use of e-cigarettes and cigarettes, but not with exclusive use of e-cigarettes. Adequate prenatal care seemed to partially buffer the elevated risk of cigarette use associated with pre-pregnancy depression in this observational research. Upon replication, our research has potential implications for clinical practice and public health policy to improve maternal and child health, especially through addressing mental health and tobacco use in the prenatal care setting.
- Open Access
- 22 March 2026
- Published by Elsevier in Addictive Behaviors
- Vol. 178, 108677
New versus continued e-cigarette use and cigarette reuptake among US adults who formerly smoked cigarettes
- 22 March 2026
- Published by Elsevier in Addictive Behaviors
- Vol. 178, 108677
Open AccessNew versus continued e-cigarette use and cigarette reuptake among US adults who formerly smoked cigarettes
- Open Access
- 10 March 2026
- Published by Elsevier in SSRN Electronic Journal
Comprehensive Assessment of Lifetime Cigarette Smoking and Its Association with Health-Related Quality of Life among Older US Adults - A Cross-sectional Study
Background: Cigarette smoking is associated with lower health-related quality of life (QOL), largely due to its causal role in cancer, cardiovascular disease, and chronic lung disease. However, prior studies have typically used limited or cross-sectional measures of smoking, which may underestimate its long-term impact on QOL. We aimed to examine the association between a comprehensive index of lifetime cigarette smoke exposure (LCSEI) and QOL among older adults in the USA.Methods: Cross-sectional analysis of N=7,001 U.S. adults ≥40y from Wave 5(2018-19) of the US PATH Study. The 11-point LCSEI included heaviness of smoking, pack-years, childhood smoking, and second-hand smoke exposure. QOL measures included PROMIS global physical and mental health (GPH, GMH) scores. We estimated the multivariable association between LCSEI scores and mean GPH or GMH, adjusting for sociodemographics, BMI, and weekly exercise.Findings: Regarding lifetime smoking, 6.7% smoked during childhood, and 16.9% currently smoked (2.1% 20 cig/d). Mean (stddev) for the LCSEI, GPH and GMH were 2.4(2.9), 14.8(3.1), and 14.5(3.3) respectively, and 15% had LCSEI scores of 5 or more. In the multivariable analysis, the LCSEI retained a strong association with GPH and GMH, -0.20(-0.23, -0.17) and -0.22(-0.25, -0.18) respectively for each 1-point increase in the LCSEI. The LCSEI—QOL associations over its 11-point range (-2.14 GPH, -2.16 GMH) were significantly higher than for extremes of education (-0.44 and -0.77) and about 30% higher than for extremes of income (-1.61 and -1.65). Sensitivity analysis found that associations were greatly attenuated but remained significant even after further adjustment for smoking-related diseases.Interpretation: These findings suggest that reducing lifetime cigarette smoking could yield gains in quality of life in older adults similar in magnitude to those associated with narrowing socioeconomic inequalities, highlighting the importance of eliminating cigarettes.
- 10 March 2026
- Published by Elsevier in SSRN Electronic Journal
Open AccessComprehensive Assessment of Lifetime Cigarette Smoking and Its Association with Health-Related Quality of Life among Older US Adults - A Cross-sectional Study
Background: Cigarette smoking is associated with lower health-related quality of life (QOL), largely due to its causal role in cancer, cardiovascular disease, and chronic lung disease. However, prior studies have typically used limited or cross-sectional measures of smoking, which may underestimate its long-term impact on QOL. We aimed to examine the association between a comprehensive index of lifetime cigarette smoke exposure (LCSEI) and QOL among older adults in the USA.Methods: Cross-sectional analysis of N=7,001 U.S. adults ≥40y from Wave 5(2018-19) of the US PATH Study. The 11-point LCSEI included heaviness of smoking, pack-years, childhood smoking, and second-hand smoke exposure. QOL measures included PROMIS global physical and mental health (GPH, GMH) scores. We estimated the multivariable association between LCSEI scores and mean GPH or GMH, adjusting for sociodemographics, BMI, and weekly exercise.Findings: Regarding lifetime smoking, 6.7% smoked during childhood, and 16.9% currently smoked (2.1% 20 cig/d). Mean (stddev) for the LCSEI, GPH and GMH were 2.4(2.9), 14.8(3.1), and 14.5(3.3) respectively, and 15% had LCSEI scores of 5 or more. In the multivariable analysis, the LCSEI retained a strong association with GPH and GMH, -0.20(-0.23, -0.17) and -0.22(-0.25, -0.18) respectively for each 1-point increase in the LCSEI. The LCSEI—QOL associations over its 11-point range (-2.14 GPH, -2.16 GMH) were significantly higher than for extremes of education (-0.44 and -0.77) and about 30% higher than for extremes of income (-1.61 and -1.65). Sensitivity analysis found that associations were greatly attenuated but remained significant even after further adjustment for smoking-related diseases.Interpretation: These findings suggest that reducing lifetime cigarette smoking could yield gains in quality of life in older adults similar in magnitude to those associated with narrowing socioeconomic inequalities, highlighting the importance of eliminating cigarettes.